Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.
Peripheral Artery Disease is a common condition that causes pain and weakness in the legs. The disease is a narrowing or blockage in the legs, and it is most often a chronic condition.